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http://www.biomedcentral.com/1471-2334/14/501RESEARCH ARTICLE Open AccessUrinary cytokines in Schistosoma haematobium-
infected schoolchildren from Tana Delta District
of Kenya
Kariuki H Njaanake1*, Paul E Simonsen2, Birgitte J Vennervald2, Dunstan A Mukoko3, Claus M Reimert2,
Kimani Gachuhi4, Walter G Jaoko1 and Benson B Estambale5Abstract
Background: Pathological changes due to infection with Schistosoma haematobium include cytokine-mediated
urinary tract inflammation. The involved cytokines may be excreted in urine and their presence in urine may
therefore reflect S. haematobium-related urinary tract pathology. The present study, for the first time, reports on the
relationship between selected cytokines in urine and infection with S. haematobium in children from an area highly
affected by this parasite.
Methods: Children aged 5–12 years from two primary schools in Tana Delta District of Kenya were examined for S.
haematobium eggs using urine filtration technique, for haematuria using dipstix and for eosinophil cationic protein
(ECP), IL-6, IFN- γ, TNF-α and IL-10 levels using ELISA, and for S. haematobium-related urinary tract pathology using
ultrasonography. In addition, venous blood was examined for serum IL-6, IFN- γ, TNF-α and IL-10 levels using ELISA.
Results: There was no significant correlation between urinary and serum levels of IL-6, IFN- γ, TNF-α or IL-10. There
was no significant difference in geometric mean intensity (GMI) in any of the serum cytokines, or in urinary TNF-α
or IFN-γ, between children with light and heavy S. haematobium infections. However, children with heavy S. haematobium
infections had significantly higher GMI of urinary IL-6 (p < 0.001) and lower GMI of urinary IL-10 (p = 0.002) than children
with light infections. There was also a significant positive correlation between urinary IL-6 and urinary ECP (p < 0.001) and
a significant negative correlation between urinary IL-10 and urinary ECP (p = 0.012).
Conclusion: Urinary IL-6 was positively correlated to and IL-10 was negatively correlated to infection intensity and urinary
tract inflammation in S. haematobium-infected children. Urinary IL-6 and IL-10 ELISA may be a useful non-invasive tool to
complement the already available tools for studying S. haematobium-related urinary tract pathology in children.Background
Schistosoma haematobium, the causative agent of urin-
ary schistosomiasis, infects over 112 million individuals
and results in over 150,000 deaths annually in sub-Saharan
Africa [1]. In chronic S. haematobium infections, eggs
lodged in the urinary tract elicit immune responses which
result in pathology mainly characterized by inflammatory
cell infiltration, granuloma formation, urinary tract fibrosis
and renal dysfunction [2,3]. Most of the available informa-
tion on pathogenesis in infected individuals is a result of
studies using markers of morbidity such as egg counts,* Correspondence: kn@uonbi.ac.ke
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unless otherwise stated.urinary eosinophil cationic protein (ECP), ultrasound and
immunological proxies of inflammation [4]. However, these
markers have inherent limitations and there is need for
more tools for use in the study of S. haematobium-related
pathology in infected individuals [4].
It has been shown that a strong pro-inflammatory
tumour necrosis factor (TNF)-α response relative to the
anti-inflammatory interleukin (IL)-10 response is associ-
ated with increased ultrasound-detectable pathology in
the urinary tracts of S. haematobium-infected children
[5]. However, there is no clear consensus on the associ-
ation between the patterns of cytokine response and
S. haematobium infections. For example, studies using
peripheral blood mononuclear cell culture demonstrated
a positive association between Th1 cytokines, such asal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[5,6]. However, another study, using whole blood cultures
from infected individuals, could not demonstrate a sig-
nificant association between Th1 or Th2 cytokines and
S. haematobium infection status or intensity [7].
At least one reason may be advanced to explain the
observed variability of cytokine patterns in relation to
schistosome-related pathology. For example, some of the
studies have concentrated on systemic cytokine re-
sponses and related them to local inflammatory pro-
cesses in the urinary tract tissue instead of studying
cytokine responses directly at the affected organ. The in-
terpretation of results may therefore be complicated by
the fact that immune cells may secrete different cytokines
in different environments and due to different stimuli [8].
Furthermore, most of the cytokines involved in local in-
flammatory processes are secreted not only by immune
cells but also by non-haematopoietic cells [9-13].
Studies on bacterial infections in the urinary tract have
demonstrated that there is substantial cytokine secretion
from the mucosa, indicating that the urinary tract mu-
cosa is an immunologically active tissue. For example, it
has been possible to induce in vivo secretion of measur-
able levels of IL-6 in urine from urinary tract mucosa of
volunteers whose urinary tracts had been colonized with
Escherichia coli [14]. In a study using epithelial cells
from the human urinary tract, E. coli elicited high levels
of IL-6 but not TNF-α whereas human peripheral blood
monocytes secreted both IL-6 and TNF-α as well as
other cytokines in response to E. coli [15]. This suggests
that there could be differences between systemic and
local mucosa cytokine responses during infections in the
urinary tract.
A study of local cytokine responses in the urinary tract
mucosa may yield important information about their
role in the pathogenesis in the affected organs during S.
haematobium infection. No studies have so far been
reported on the relationship between S. haematobium-
related urinary tract pathology and urinary cytokines
despite the importance of the pathological mucosal in-
flammation in infections with this parasite. The present
study examined the relationship between selected urin-
ary and serum cytokines [IL-6, interferon-γ (IFN-γ),
TNF-α, and IL-10], urinary ECP, and S. haematobium
infection and morbidity in children from two village pri-
mary schools in Tana Delta District of Kenya.
Methods
Study area and study design
The cross-sectional study was carried out in Tana Delta
District, northern coastal Kenya. Children aged 5 –
12 years were recruited into the study from local pri-
mary schools in two villages (Kau and Ozi) located along
the Tana River with a distance of about 5 km betweenthem. One urine sample was collected from each child
between 10:30 am and 12:00 pm on each of three con-
secutive days and examined for S. haematobium eggs.
Urine samples were analyzed for cytokines and eosino-
phil cationic protein (ECP). One venous blood sample
was collected from each child and analyzed for serum
cytokines. The urinary tract of each child was examined
by ultrasonography for S. haematobium infection-related
pathology.
Ethical review and approval to carry out the study was
obtained from the Kenyatta National Hospital/ University
of Nairobi Ethics and Research Committee in Kenya
(Ethical approval No. P91/3/2009). For each child’s
participation, a written informed consent was obtained
from one of the parents. All children were treated with
praziquantel (40 mg/kg body weight) at the end of the
study.
Urine examination for S. haematobium eggs
Ten milliliter of each of the three consecutive urine
samples from each child was filtered through a polycar-
bonate filter (12 μm pore-size; GE Water & Process
Technologies Inc., USA) and the filter was examined
microscopically for S. haematobium eggs [16]. The results,
based on arithmetic mean of the three egg counts from
each child, were classified into negative, light (1–49 eggs/
10 ml urine) or heavy infections (≥50 eggs/10 ml urine)
according to WHO [17,18].
Urinary and serum cytokine ELISA
Aliquots of well suspended urine samples were collected
from the children for cytokine and ECP analysis. The
samples were kept cold in a cool box during transport to
the laboratory where they were frozen at – 20°C within
4 hrs after collection and until used for cytokine or ECP
analysis. One venous blood sample (2 ml) was collected,
in plain Nunc tubes, from each child in the field and
allowed to clot at room temperature for 30 minutes. It
was then transported to the laboratory within 4 hrs after
collection, in a cool box, where it was centrifuged at
1,000 × g for 10 minutes to remove the clot. The result-
ant serum was transferred to a new Nunc tube and
frozen at – 20°C until use in cytokine ELISA.
Serum and non-filtered urine samples were thawed,
re-suspended and part of each sample (100 μl) was ana-
lysed for the concentrations of IL-6, IL-10, TNF-α and
IFN-γ through solid phase sandwich ELISA using the
BD OptEIATM ELISA Kit II format (BD Biosciences,
United States), with a lower detection limit of 0.01 pg/
ml, according to the manufacturer’s instructions. The
assays were performed at room temperature and both
undiluted serum and urine samples were treated in a
similar way. A single test was run per sample and the
ELISA plates were read at 450 nm within 30 minutes
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lated. Blood cell counts were performed on the children’s
blood samples (data not shown) and none had neutrophilia,
a marker of bacterial infections. It was therefore assumed
that the measured urinary cytokine levels were mainly due
to infections with S. haematobium.
Urinary ECP ELISA
Extraction of urine samples for and measurement of
urinary ECP was carried out as previously explained in
detail [19]. Briefly, one volume of well-suspended urine was
mixed with 1 volume of extraction buffer (1% N-cetyl-N,N,
N-trimethyl-ammonium bromide [CTAB] in 0.15 M NaCl).
After 1 cycle of freeze-thawing, the sample was mixed on a
vortex-mixer and centrifuged for 10 min at 3,000 X g at
4°C. The supernatants containing the extracted proteins
were removed and used for ECP determinations by a
polyclonal sandwich type ELISA using the biotin-avidin-
peroxidase amplification step which measures ECP in the
range of 15–1,000 pg/ml. ECP purified from extracts of hu-
man blood eosinophils was used as standards. Before meas-
urement, the standard and urine extracts were diluted by
adding 200 μl of standard or urine extract to 800 μl of sam-
ple buffer (0.1% Tween 20, 0.1% CTAB, 20 mM EDTA,
0.2% human serum albumin, and 0.1% NaN3 in phosphate-
buffered saline, pH 7.4). Reading of the ECP concentrations
was done using Reading Microplate Manager 4.0® (Bio-Rad
Laboratories, Inc.) software at a measurement wavelength
of 490 nm and reference wavelength of 595 nm. Samples
were analysed in duplicates and the average of the two
readings for each child calculated.
Urinary tract ultrasound examination
Ultrasound examination of the urinary tracts of each child
was performed by an experienced ultrasonographer using a
portable convex sector scanner (SSD-500®; Aloka, Tokyo,
Japan) according to the Niamey protocol [20] and bladder,
ureter and kidney pathology was recorded. If any kidney
and/ or ureter dilatation was observed the child was asked
to empty the bladder and come back for re-examination.
Test for haematuria
Urine samples were examined visually for presence or
absence of blood and using dipstix (URISCAN®, YD
Diagnostics, Korea) according to the manufacturer’s in-
structions for occult blood (microhaematuria). Trace
haematuria was regarded as negative and anything above
trace was regarded as positive for microhaematuria.
Statistical analysis
Data were analysed statistically using Stata (Version 12).
Geometric mean intensities (GMI) were calculated for
non-normally distributed continuous variables such as S.
haematobium egg counts and cytokine levels using theformula: antilog10 [(Σlog10 x + 1)/n)]-1, with n being
the number of children examined. GMI were compared
between groups by using t-test on log(x + 1)-transformed
values. Standard errors (S.E.) on GMI were calculated as:
antilog [mean of log-transformed (x + 1) ± S.E. on log
transformed (x + 1)]-1. Proportions such as prevalence
were compared between groups using Pearson χ2 test.
The linear association between continuous variables was
assessed using Pearson correlation analysis. p-values less
than 0.05 were considered significant in all tests.
Results
Study population
One hundred and fifty-eight (158) children, 71 boys and
87 girls, participated in the study. The mean age of the
children was 9.8 years but boys were significantly older
than girls (10.1 and 9.5 years old, respectively, p = 0.039).
The overall prevalence of S. haematobium infections
based on microscopic examination of three urine sam-
ples from each child was 94.3%. There was no significant
difference in prevalence of infections between boys and
girls (96.8% and 93.1%, respectively, p = 0.52). The over-
all GMI was 64.8 eggs/ 10 ml urine but boys had signifi-
cantly higher GMI than girls (91.9 and 48.6 eggs/10 ml
urine, respectively, p = 0.049).
As the area is highly prevalent for S. haematobium
and the sensitivity of the urine filtration technique is
relatively low in individuals with low intensities [18,21]
it was assumed that the 9 egg-negative children were
also infected but that the eggs were missed during mi-
croscopy. The egg-negative children were thus grouped
together with those with light infections in the following
analyses.
Relationship between urinary and serum cytokine levels
The urine and serum samples from 158 children were
analysed for levels of IL-6, TNF-α, IFN-γ and IL-10, and
the geometric mean intensities (GMI) are shown in Figure 1.
Considering all 158 children, the GMI of serum cytokines
were higher than those of urinary cytokines.
The correlation between urinary and serum cytokines
was assessed for all 158 children using correlation
analysis. Overall, there was no significant correlation
between levels of urinary and serum IL-6 (r = −0.01,
p = 0.87), TNF-α (r = −0.04, p = 0.59), IFN-γ (r = −0.05,
p = 0.50) or IL-10 (r = −0.03, p = 0.70).
For serum TNF-α, IFN-γ and IL-10 there were 40, 39
and 27 children, respectively, who had levels below the
lower detection limit of the test. For each of the cytokines,
these children were not significantly different from the rest
of the children in the study group with regard to age, sex or
S. haematobium infection intensity (data not shown). They
were regarded as non-responders for the respective serum
cytokines, and since they could negatively skew the
Figure 1 GMI of urinary and serum IL-6, TNF-α, IFN-γ and IL-10.
n = 158. Orange bars = Urinary cytokines; Red bars = Serum cytokines.
Vertical lines indicate standard errors (±S.E.).
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cluded in the subsequent analyses of the respective cy-
tokines. However, all 158 children had detectable levels
of urinary cytokines.
Relationship between cytokines and S. haematobium
infection intensity
The GMI of urinary and serum IL-6, TNF-α, IFN- γ and
IL-10 in relation to S. haematobium infection intensity
are shown in Figures 2a,b,c and d, respectively. There
were no significant differences in GMI of serum IL-6,
TNF-α, IFN-γ or IL-10 between children with light and
children with heavy S. haematobium infections. Simi-
larly, there were no significant differences in GMI of
urinary TNF-α or IFN-γ between children with light and
heavy S. haematobium infections. Considering all 158
children, those with light S. haematobium infections
however had significantly lower GMI of urinary IL-6 and
significantly higher GMI of urinary IL-10 than children
with heavy S. haematobium infections (p < 0.001 and p =
0.002, respectively). The results remained significant
when the 9 S. haematobium egg-negative children were
excluded from this analysis, with children with light S.
haematobium infections having significantly lower GMI
of urinary IL-6 and significantly higher GMI of urinary
IL-10 than those with heavy S. haematobium infections
(p < 0.001 and p = 0.007, respectively).
Relationship between cytokines, urinary tract pathology
and morbidity markers
Eight children did not return for ultrasound examination
after voiding their bladders and were therefore excludedin the analyses of ultrasound detectable pathology. Over-
all, urinary tract pathology was reported in 62 (41%)
children. Lower urinary tract pathology was reported in
52 (35%) of the children whereas upper urinary tract
pathology was reported in 17 (11%) of the children,
which had mean ages of 10.2 years and 10.2 years, re-
spectively. Seven of the children had both lower and
upper urinary tract pathology.
There were no significant differences in GMI of urin-
ary IFN-γ or IL-10 between children with and those
without urinary tract pathology (p = 0.81 and 0.19, re-
spectively). Children with urinary tract pathology, how-
ever, had significantly higher GMI of urinary IL-6 and
significantly lower GMI of urinary TNF-α than those
without (p = 0.016 and 0.015, respectively). There were
no significant differences in GMI of serum IL-6, TNF-α,
IFN-γ or IL-10 between children with and those without
general urinary tract pathology (p = 0.43, 0.26, 0.33 and
0.23, respectively).
Children with haematuria had significantly higher
GMI of urinary IL-6 (p < 0.001; n = 158) but lower GMI
of urinary IL-10 (p = 0.005, n = 158) than children with-
out haematuria. There was however no significant
difference between children with haematuria and those
without in GMI of urinary TNF-α (p = 0.11; n = 158) or
IFN-γ (p = 0.29; n = 158). Similarly, there were no signifi-
cant differences between children with haematuria and
those without in GMI of serum IL-6 (p = 0.63; n = 158),
TNF-α (p = 0.38; n = 118), IFN-γ (p = 0.34; n = 119) or
IL-10 (p = 0.69; n = 131).
Data on urinary ECP from 4 children were not avail-
able and another 11 children had urinary ECP levels
below the lower detection limit of the assay. However,
there was no significant difference in serum cytokine
levels between these 15 children and those whose urinary
ECP data were available (data not shown). Considering the
non-responders for the serum cytokines mentioned above,
analyses of the relationship between serum cytokines and
urinary ECP levels were only done for children who were
responders for serum cytokines and had urinary ECP data
available. These were 143 children for serum IL-6, 105 for
TNF-α, 107 for IFN-γ and 118 for IL-10. Analyses of the re-
lationship between urinary cytokines and urinary ECP levels
were done for all 143 children whose urinary cytokine and
ECP data were available. The linear association between
urinary or serum cytokines and urinary ECP were assessed
using correlation analysis for all children whose urinary
ECP data were available.
There was a significant positive correlation between
levels of urinary ECP and S. haematobium infection
intensity (r = 0.23; p = 0.005; n = 143) but there was no
significant correlation between levels of urinary ECP
and serum IL-6 (r = −0.08, p = 0.32, n = 143), TNF-α
(r = −0.11, p = 0.29; n = 105), IFN-γ (r = −0.11, p = 0.26;
Figure 2 GMI of urinary and serum IL-6 (a), TNF-α (b), IFN-γ (c) and IL-10 (d) in relation to S. haematobium infection intensity. p-values
above the bars indicate significance level of differences between light and heavy S. haematobium infection intensity groups. Blue bars = Light
infection; Red bars = Heavy infection. n = number of children in group. Vertical lines indicate standard errors (±S.E.).
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was a highly significant positive correlation between
levels of urinary ECP and urinary IL-6 (r = 0.54, p <
0.001; n = 143) (Figure 3a) and a significant negative
correlation between levels of urinary ECP and urinary
IL-10 (r = −0.21, p = 0.012; n = 143) (Figure 3b). There
was no significant correlation between levels of urinary
ECP and TNF-α (r = −0.02, p = 0.80; n = 143) or IFN-γ
(r = 0.02, p = 0.85; n = 143).
Discussion
The present study reports for the first time the relationship
between urinary cytokines IL-6, IFN-γ, TNF-α and IL-10,
and S. haematobium infection and infection-associatedurinary tract pathology in primary school children. Levels
of urinary cytokine were lower than those of serum cyto-
kines and there was no correlation between levels of urin-
ary and serum IL-6, IFN-γ, TNF-α and IL-10 among the
children. These findings concur with those of a previous
study which demonstrated differences between urine and
serum cytokine levels in children with bacterial infections
of the urinary tract [22]. These findings suggest that there
may be differences between systemic and local mucosal
cytokine production or secretion during infections in the
urinary tract.
A correlation between ex vivo cytokine secretion by
antigen-stimulated peripheral blood cells and schistosome-
related morbidity has previously been demonstrated both
Figure 3 Scatter diagram showing the association between
urinary ECP and urinary IL-6 (a) and between urinary ECP and
urinary Il-10 (b). n = 143. The trend-lines shown are the linear
regression lines.
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mansoni-animal models where some features of the im-
mune responses evoked in naturally infected humans are
similar to those in controlled S. mansoni-animal model
[5,6,23-25]. In contrast to findings from these studies, the
present study showed no relationship between levels of
serum IL-6, TNF-α, IFN-γ or IL-10 and markers of S.
haematobium-related morbidity such as intensity of infec-
tion, haematuria or urinary ECP. There was no correlation
between this pathology and levels of serum IL-6, TNF-α,
IFN-γ or IL-10. It is noteworthy that the present study
assessed levels of serum cytokines whereas previous studies
have assessed in vitro cytokine production by in vitro cul-
tured cells. For example, cytokine inhibitors are commonly
present in sera of patients and may influence cytokine levelsin serum samples as opposed to levels of in vitro produced
cytokines [26]. The explanation for the differences may
therefore, at least partially, be explained by differences be-
tween in vivo and in vitro conditions [27,28].
Significantly higher levels of urinary IL-6 were ob-
served in children with heavy S. haematobium infec-
tions, urinary tract pathology and haematuria than in
children with light S. haematobium infections, and those
without urinary tract pathology or haematuria. In addition,
there was a significant positive correlation between levels of
urinary IL-6 and urinary ECP. These findings suggest that
the observed high levels of urinary IL-6 were as a result of
local inflammation evoked by S. haematobium eggs in the
urinary tract. Urinary IL-6 may have been produced by
inflammtory cells such as eosinophils or by uroepithelial
cells [15,29] in schistosome egg-driven granulomas in the
urinary tract whereafter it can be found in urine.
IL-10 is a potent anti-inflammatory cytokine produced by
lymphocytes [27,30,31]. Several studies have demonstrated
that IL-10 is involved in down-modulating pathological
inflammatory responses in schistosomiasis [9,24,32]. Al-
though levels of urinary IL-10 were significantly negatively
correlated with levels of urinary ECP, infection intensity
and haematuria, there was no significant difference in
levels of urinary IL-10 between children with and
without ultrasound-detectable urinary tract pathology.
Ultrasound mainly detects late stage pathological
changes characterised by fibrosis and calcification
whereas urinary ECP is a marker of inflammation
which characterises early pathology in the urinary tract
during S. haematobium infections [4]. These results
therefore suggest that urinary IL-10 is locally secreted
and is mainly associated with early urinary tract path-
ology due to tissue-lodged S. haematobium eggs.
In a study, using cultures of peripheral blood mono-
nuclear cells from infected children, it was demonstrated
that TNF-α, a pro-inflammatory cytokine, was positively
associated with S. haematobium-related bladder path-
ology [5]. In the present study, however, there was no
significant difference in levels of urinary TNF-α between
children with light and those with heavy S. haematobium
infections or between those with and without haema-
turia although children without urinary tract pathology
had significantly higher levels of urinary TNF-α than
those with pathology. No immediate explanation could
be advanced for this and further studies are needed to
clarify this observation. In a recent mouse model study
of urogenital schistosomiasis in which viable S. haemato-
bium eggs were injected directly into the bladder wall
thus recapitulating inflammatory cell activation and infiltra-
tion, urinary tract granuloma formation and fibrosis
observed in infected humans, there was no significant
changes in IFN-γ levels [33]. Although this study assessed
systemic cytokines, the findings were in agreement with
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ciation between infection intensity or urinary tract path-
ology and IFN-γ levels hence no clear role of this cytokine
in development of pathology. A recent study has shown
that S. haematobium-infected children with bladder path-
ology had a significantly higher percentage of Th17 cells
than those without pathology [34]. We do not know if urin-
ary tract pathology was accompagnied by an increased level
of IL-17 in serum or urine since Il-17 has not been mea-
sured in the current study.
Conclusions
The present study is the first report on significant
associations between urinary cytokine levels and S.
haematobium infection and urinary tract pathology.
Cytokines can be assessed non-invasively in urine sam-
ples and may potentially be important non-invasive tools
in studying the inflammatory response leading to S.
haematobium-related urinary tract pathology. This study
may therefore provide an important scaffold for further
studies on tissue inflammation and pathogenesis in S.
haematobium infection and on how levels of local
cytokine production change following treatment with
praziquantel.
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